指南与共识儿科与产科急症消化、代谢与肾脏急症

2011年AAP尿路感染指南的诊断与影像学推荐能否用于<2月龄婴儿?

Can diagnostic and imaging recommendations from the 2011 AAP UTI guidelines be applied to infants <2 months of age?
指南 / 共识 · J Pediatr Urol · 2022-06-20
一句话结论队列研究提示AAP指南的尿常规、尿培养诊断标准和普遍RBUS可安全用于<2月龄fUTI婴儿,VCUG推荐适用性待明确。

该队列研究纳入2016至2018年某儿童医院≤24月龄因首次发热性尿路感染(fUTI)住院的137例患者(中位年龄70天),比较<2月龄与2-24月龄组的人口学、临床、尿液检查、影像利用与结果及临床结局。两组尿常规和尿培养结果无差异;<2月龄组发热时间更短、最高体温更低、白细胞计数更低,但VCUG被推荐和完成更频繁。两组1年内UTI复发(13.6% vs 14.1%,p=1.00)、fUTI复发(13.6% vs 7.7%,p=0.40)、90天再入院(6.8% vs 6.4%,p=1.00)和90天急诊再就诊(22.0% vs 20.5%,p=1.00)均无差异。作者认为AAP指南的尿常规、尿培养诊断标准和普遍RBUS可安全用于<2月龄婴儿,VCUG推荐需进一步研究明确。

要点

  • <2月龄组与2-24月龄组尿常规和尿培养结果无差异,支持将AAP指南的尿常规、尿培养诊断标准用于<2月龄fUTI婴儿。
  • <2月龄组VCUG被推荐和完成更频繁,但两组RBUS或VCUG结果无差异,VCUG推荐适用性需进一步明确。
  • 两组1年内UTI复发(13.6% vs 14.1%,p=1.00)、fUTI复发(13.6% vs 7.7%,p=0.40)、90天再入院(6.8% vs 6.4%,p=1.00)和90天急诊再就诊(22.0% vs 20.5%,p=1.00)均无差异。
  • <2月龄组较2-24月龄组更常为男性(71.2% vs 43.6%,p=0.002),发热时间更短、最高体温更低、白细胞计数更低。
  • 作者认为AAP指南的普遍RBUS推荐可安全用于<2月龄婴儿,但VCUG最佳推荐需进一步研究。

适用人群与场景

  • 2016至2018年某儿童医院≤24月龄因首次发热性尿路感染(fUTI)住院的患者,共137例,中位年龄70天,55.5%男性(92.1%未行包皮环切),53.3%西班牙裔/拉丁裔,89.8%为首次fUTI。
  • 比较<2月龄组与2-24月龄组;AAP 2011指南因数据不足将<2月龄婴儿排除在外。

研究设计与关键结果

  • 研究类型:队列研究,纳入2016至2018年某儿童医院≤24月龄因fUTI住院的患者137例,数据通过前瞻性生成的电子病历记录模板收集并辅以回顾性病历复习,采用单变量和双变量统计比较年龄组。
  • 主要结局:两组尿常规和尿培养结果无差异;<2月龄组较2-24月龄组发热时间更短、最高体温更低、白细胞计数更低;<2月龄组VCUG被推荐和完成更频繁,但两组RBUS或VCUG结果无差异。
  • 人口学:仅<2月龄组男性比例高于2-24月龄组(71.2% vs 43.6%,p=0.002),其余人口学无差异。
  • 次要结局:1年内UTI复发<2月龄组13.6% vs 2-24月龄组14.1%(p=1.00);1年内fUTI复发13.6% vs 7.7%(p=0.40);90天再入院6.8% vs 6.4%(p=1.00);90天急诊再就诊22.0% vs 20.5%(p=1.00)。

证据类型、等级与局限

  • 证据类型:队列研究(某儿童医院单中心数据,2016至2018年)。
  • 作者结论:实验室检查和RBUS推荐可安全用于<2月龄婴儿;VCUG推荐需进一步研究明确。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,AAP 2011指南的尿常规和尿培养诊断标准以及普遍RBUS推荐可安全应用于<2月龄fUTI婴儿。
  • 作者指出,鉴于VCUG利用差异,VCUG指南推荐对<2月龄患者的适用性需要进一步澄清;进一步研究需明确最佳VCUG推荐。

指南或共识出处

  • 2011年美国儿科学会(AAP)儿童2-24月龄首次发热性尿路感染诊断与管理指南。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: In 2011, the American Academy of Pediatrics (AAP) published guidelines regarding diagnosis and management of children 2-to-24-months-old with initial febrile urinary tract infection (fUTI). Available data were insufficient to determine whether evidence from studies of 2-to-24-month-olds applies to those <2-months-old, so they were excluded.

OBJECTIVE: This study aimed to 1) compare demographic, clinical, imaging and outcomes between patients <2-months-old and those 2-to-24-months-old hospitalized with fUTI, and 2) assess whether diagnostic and imaging recommendations of the AAP 2011 guidelines apply to those <2-months-old.

STUDY DESIGN: A cohort study of patients ≤24-months-old hospitalized at a children's hospital with fUTI from 2016 to 2018 was conducted. Data were collected via a prospectively generated electronic medical record note template, supplemented with retrospective chart review. Primary outcomes included differences in demographics, clinical presentation, urine culture results, and imaging utilization/results by age group. Secondary outcomes included surgical procedures, UTI recurrence, and 90-day all-cause readmissions and emergency department (ED) revisits. Univariate and bivariate statistics were utilized to compare age groups.

RESULTS: Overall, 137 patients were included (median age 70 days, 55.5% male [92.1% uncircumcised], 53.3% Hispanic/Latino, 89.8% 1st fUTI). There were no demographic differences between groups, except children <2-months-old were more frequently male (71.2 vs 43.6%, p = 0.002). The Summary Table compares clinical factors and imaging utilization by age. There were no differences in urinalysis or urine culture results between groups. Patients <2-months-old had shorter fever duration, lower maximum temperature, and lower white blood cell counts. Voiding cystourethrograms (VCUGs) were recommended and obtained more frequently in patients <2-months-old, but there were no differences in renal and bladder ultrasound (RBUS) or VCUG results between age groups. There were no differences in UTI recurrence (13.6% of <2-months-old vs 14.1% of 2-to-24-months-old, p = 1.00) or fUTI recurrence (13.6 vs 7.7%, p = 0.40) within 1 year, 90-day readmission (6.8 vs 6.4%, p = 1.00), or 90-day ED revisit (22.0 vs 20.5%, p = 1.00).

DISCUSSION: There were minimal differences between the <2-months-old and 2-to-24-months-old age groups in demographics, laboratory (including microbial) or imaging results, or clinical outcomes. Patients <2-months-old were more frequently male and less ill. These data support applying urinalysis and urine culture diagnostic criteria, and universal RBUS, from the AAP guidelines to patients <2-months-old. Given utilization differences, applicability of VCUG guideline recommendations requires further clarification for patients <2-months-old.

CONCLUSION: Laboratory testing and RBUS recommendations from the AAP guidelines may be safely applied to infants <2-months-old. Further studies are needed to clarify optimal VCUG recommendations.

来源:J Pediatr Urol,查看原文。版权归原作者所有。

参考来源

  1. Walton RF, Shannon R, Rague JT, et al. Can diagnostic and imaging recommendations from the 2011 AAP UTI guidelines be applied to infants <2 months of age? J Pediatr Urol. 2022. PMID: 35781184. doi:10.1016/j.jpurol.2022.06.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。